◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

CELLDEX THERAPEUTICS, INC.

CIK: 744218 SIC: 2835
$2.97M
Revenue
$-258.76M
Net Income
-
Gross Margin
-9675.62%
Op. Margin
$-367.67M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 14 of 14 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
+ Total Revenue $2.97M $1.54M $7.02M $6.88M $2.36M $4.65M $7.42M $3.57M $9.54M $12.74M $6.79M $3.59M $4.11M $11.20M $9.27M
Revenue Growth % 92.2% -78.0% 2.0% 192.0% -49.3% -37.3% 107.6% -62.5% -25.2% 87.8% 89.2% -12.8% -63.3% 20.9% nan%
Cost of Revenue - $200.00K $200.00K $300.00K - - - - - - - - - - -
+ Gross Profit - $1.34M $6.82M $6.58M - - - - - - - - - - -
Gross Margin % nan% 87.1% 97.2% 95.6% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Operating Expenses $288.91M $288.91M $202.10M $161.43M $117.59M $75.89M $70.77M $58.60M $165.97M $134.27M $139.70M $126.02M $85.55M $69.28M $52.66M
Research & Development $245.07M $245.07M $163.55M $118.01M $82.26M $53.31M $42.53M $42.67M $66.45M $96.17M $102.73M $104.38M $67.40M $47.40M $32.44M
+ Operating Income $-287.37M $-287.37M $-195.08M $-154.54M $-115.23M $-71.24M $-63.35M $-55.03M $-156.44M $-121.53M $-132.92M $-122.43M $-81.44M $-58.08M $-43.40M
Operating Margin % -9675.6% -18599.8% -2778.9% -2245.3% -4889.0% -1531.8% -854.1% -1540.2% -1640.1% -953.7% -1958.7% -3414.1% -1981.1% -518.5% -468.4%
Interest Expense - - - - - - - - - - - - $927.00K $1.58M $1.80M
Other Income/Expense - - - - - - - - - - - - - - $396.00K
Income Before Tax - $-258.76M $-157.86M $-141.43M $-112.33M $-70.74M $-60.95M $-50.88M $-151.95M $-117.31M $-128.53M - - - $-44.80M
Income Tax Expense - - - - - $-227.00K $-1.17M - $-765.00K $-24.28M - - - - -
+ Net Income $-258.76M $-258.76M $-157.86M $-141.43M $-112.33M $-70.51M $-59.78M $-50.88M $-151.18M $-93.03M $-128.53M $-118.08M $-81.55M $-59.12M $-44.80M
Net Margin % -8712.4% -16748.0% -2248.8% -2054.8% -4765.6% -1516.0% -805.9% -1424.0% -1585.1% -730.1% -1894.0% -3292.8% -1983.7% -527.8% -483.5%
Basic EPS -3.90 -3.90 -2.45 -2.92 -2.40 -1.64 -2.02 -3.51 nan nan nan nan nan nan nan
Diluted EPS -3.90 -3.90 -2.45 -2.92 -2.40 -1.64 -2.02 -3.51 nan nan nan nan nan nan nan
Basic Shares Outstanding - 66.4M 64.4M 48.4M 47K 43K 30K 15K - - - - - - 39.5M
Diluted Shares Outstanding - 66.4M 64.4M 48.4M 47K 43K 30K 15K - - - - - - 39.5M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Cash & Cash Equivalents $28.87M $28.36M $34.81M $29.43M $39.14M $43.84M $11.23M $24.31M $40.29M $42.46M $28.02M $169.40M $24.90M $11.90M
Short-term Investments $489.70M $696.92M $388.78M $275.52M $369.11M $150.59M $53.15M $69.71M - - - - - $41.41M
Other Current Assets $14.08M $21.18M $5.47M $12.39M $2.42M $1.62M $1.30M $1.90M $3.45M $4.01M $3.52M $1.72M $1.11M $1.20M
Total Current Assets $534.66M $747.16M $431.69M $317.69M $410.84M $197.84M $66.70M $99.08M $144.76M $195.57M $204.99M $305.19M $85.11M $54.68M
Property Plant & Equipment $5.33M $4.35M $4.06M $3.75M $3.55M $3.81M $4.03M $6.11M $10.37M $13.19M $10.54M $9.97M $7.21M $9.09M
Goodwill - - - - - - - - $90.98M $90.98M $8.96M $8.96M $8.96M $8.96M
Intangible Assets $27.19M $27.19M $27.19M $27.19M $27.19M $30.69M $48.69M $48.69M $67.59M $81.49M $21.81M $22.82M $23.83M $24.92M
Other Non-current Assets $13.36M $9.75M $107.00K $104.00K $104.00K $41.00K $41.00K $1.93M $1.93M $2.13M $1.72M $148.00K $424.00K $329.00K
Total Assets $582.98M $792.34M $465.63M $352.74M $444.65M $235.84M $122.93M $155.81M $315.62M $383.36M $248.01M $347.10M $125.54M $97.99M
Accounts Payable $1.18M $3.27M $3.49M $3.34M $1.23M $1.05M $1.17M $1.07M $1.72M $1.74M $2.60M $2.24M $745.00K $935.00K
Accrued Liabilities $47.03M $33.84M $22.03M $12.84M $12.00M $8.46M $6.50M $7.01M $19.45M $28.66M $19.30M $17.18M $10.96M $7.01M
Other Current Liabilities $1.23M $942.00K $3.99M $990.00K $1.55M $3.37M $2.03M $4.53M $6.57M $4.83M $2.59M $928.00K $388.00K $219.00K
Total Current Liabilities $50.99M $39.50M $31.12M $18.61M $16.53M $14.21M $11.64M $12.60M $27.74M $35.22M $24.49M $20.35M $17.68M $14.30M
Other Non-current Liabilities $4.04M $3.47M $4.40M $5.33M $7.35M $10.12M $15.55M $19.15M $51.52M $82.70M $11.86M $6.95M $6.34M $5.97M
Total Liabilities $55.82M $45.34M $36.46M $26.53M $25.18M $26.48M $28.91M $31.75M $79.25M $117.93M $36.35M $27.30M $29.77M $29.27M
Common Stock $67.00K $66.00K $56.00K $47.00K $47.00K $40.00K $17.00K $12.00K $139.00K $121.00K $90.00K $89.00K $64.00K $44.00K
Retained Earnings $-1.81B $-1.56B $-1.40B $-1.26B $-1.14B $-1.07B $-1.01B $-962.44M $-812.52M $-719.49M $-463.76M $-345.68M $-264.13M $-205.01M
Total Stockholders Equity $527.16M $747.00M $429.17M $326.20M $419.48M $209.36M $94.03M $124.06M $236.37M $265.43M $211.66M $319.80M $95.77M $68.72M
Total Liabilities & Equity $582.98M $792.34M $465.63M $352.74M $444.65M $235.84M $122.93M $155.81M $315.62M $383.36M $248.01M $347.10M $125.54M $97.99M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Net Income - $-258.76M $-157.86M $-141.43M - - - - - - - - - - -
Depreciation & Amortization $5.99M $3.38M $3.18M $3.01M $2.90M $3.07M $3.93M $4.86M $3.58M $4.41M $3.10M $2.39M $1.93M $2.05M $2.25M
Stock-based Compensation $64.04M $36.22M $34.24M $23.89M $15.61M $8.95M $3.92M $4.55M $8.08M $12.31M $15.32M $6.85M $4.55M $2.30M $2.34M
Operating Cash Flow $-363.69M $-210.94M $-157.78M $-107.29M $-103.73M $-60.91M $-40.40M $-46.41M $-75.23M $-99.93M $-113.04M - - - -
Capital Expenditure $3.97M $2.71M $1.92M $1.82M $1.83M $1.25M $1.55M $731.00K $813.00K $1.79M $2.75M $1.93M $4.22M $303.00K $509.00K
Purchases of Investments $810.40M $384.50M $789.92M $424.56M $188.97M $389.88M $220.32M $95.38M $171.18M $170.98M $173.93M $148.31M $112.12M $69.25M $52.72M
Investing Cash Flow $344.82M $209.07M $-290.13M $-105.78M $89.94M $-216.16M $-98.22M $17.08M $29.82M $46.47M $68.91M - - - -
Debt Repayment - - - - - - $2.96M - - - - - - - -
Stock Issued - - $432.30M $216.22M - $269.89M $170.79M $16.25M $29.02M $51.02M $13.95M - $295.70M $83.78M $36.02M
Financing Cash Flow $2.85M $2.39M $441.45M $218.46M $4.08M $272.37M $171.23M $16.26M $29.44M $51.29M $14.48M - - - -
Net Change in Cash $-16.02M $515.00K $-6.46M $5.38M $-9.71M $-4.69M $32.60M $-13.08M $-15.98M $-2.17M $-29.65M $-141.38M - - -
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue - - $1.42M -
Operating Expenses $73.62M - $201.64M -
Research & Development $62.93M - $169.74M -
Operating Income $-73.62M - $-200.21M -
Net Income $-67.04M $-35.84M $-177.44M -
Basic EPS -1.01 - -2.67 -
Diluted EPS -1.01 - -2.67 -
Basic Shares Outstanding $66.42K - $66.40K -
Diluted Shares Outstanding $66.42K - $66.40K -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $36.04M $28.36M
Short-term Investments $547.19M $696.92M
Other Current Assets $21.03M $21.18M
Total Current Assets $604.34M $747.16M
Property Plant & Equipment $4.83M $4.35M
Intangible Assets $27.19M $27.19M
Other Non-current Assets $9.36M $9.75M
Total Assets $648.44M $792.34M
Accounts Payable $4.27M $3.27M
Accrued Liabilities $39.72M $33.84M
Other Current Liabilities $930.00K $942.00K
Total Current Liabilities $46.47M $39.50M
Other Non-current Liabilities $2.54M $3.47M
Total Liabilities $50.08M $45.34M
Common Stock $66.00K $66.00K
Retained Earnings $-1.73B $-1.56B
Total Stockholders Equity $598.36M $747.00M
Total Liabilities & Equity $648.44M $792.34M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-67.04M $-35.84M $-177.44M -
Depreciation & Amortization - - $2.56M -
Stock-based Compensation - - $27.31M -
Operating Cash Flow - - $-147.00M -
Capital Expenditure - - $1.43M -
Purchases of Investments - - $329.71M -
Investing Cash Flow - - $153.65M -
Financing Cash Flow - - $1.04M -
Net Change in Cash - - $7.68M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...